Brain derived neurotrophic factor (BDNF) delays onset of pathogenesis in transgenic mouse model of spinocerebellar ataxia type 1 (SCA1)

Keyphrases

• Spinocerebellar Ataxia 100%
• Transgenic Mouse Model 100%
• Brain-derived Neurotrophic Factor 100%
• Ataxin-1 83%
• Motor Deficits 33%
• Purkinje Neuron 33%
• Novel Therapeutics 16%
• Neurodegeneration 16%
• Growth Factors 16%
• Cerebellum 16%
• Protective Behavior 16%
• Neurodegenerative Diseases 16%
• Disease Stage 16%
• Cerebellar Granule Neurons 16%
• Disease Onset 16%
• Intraventricular 16%
• Gene Expression Analysis 16%
• Decreased Expression 16%
• Neuron-specific 16%
• Toxic Effects 16%
• Osmotic Pump 16%
• Delayed Onset 16%
• Abnormal Expansion 16%
• Compensating Factor 16%
• CAG Repeat 16%
• Neurotrophic Factor Expression 16%

Neuroscience

• Brain-Derived Neurotrophic Factor 100%
• Spinocerebellar Ataxia 100%
• Ataxin 1 83%
• Neurodegenerative Disorder 16%
• Cerebellum 16%
• Expression Analysis 16%
• Neurotrophic Factor Expression 16%
• Gene Expression 16%
• CAG Repeat 16%
• Growth Factor 16%
• Neurodegeneration 16%